Dana Mead joined Kleiner Perkins Caufield & Byers as a partner in May 2005 to work in the firm's life sciences practice. He leverages experience accrued from his venture-funded, startup management roles and board participation to support entrepreneurs and innovators dedicated to making a real difference in the lives of millions suffering from life-limiting diseases. Mead serves on the boards of Apnicure, Awarepoint, Corventis, Inspire Medical Systems, Intersect ENT, Invuity, Navigenics, Pulmonx, Spinal Modulation, Spiracur and Voyage Medical.

For the past 30 years, Mead's career has focused on identifying new medical technologies, developing new markets and therapies, and building world-class management teams. He has worked with physician thought leaders around the world representing 12 medical specialties.

Before joining KPCB, Mead was president of Guidant Vascular Intervention, a fully integrated billion-dollar division with more than 4,500 employees. He joined Gui...

Go to complete bio »
Speaker's website »